The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers
Open accessAbstract
Tobacco smoke contains multiple classes of established carcinogens including benzo(a)pyrenes, polycyclic aromatic hydrocarbons, and tobacco-specific nitrosamines. Most of these compounds exert their genotoxic effects by forming DNA adducts and generation of reactive oxygen species, causing mutations in vital genes such as K-Ras and p53. In addition, tobacco-specific nitrosamines can activate nicotinic acetylcholine receptors (nAChR) and to a certain extent β-adrenergic receptors (β-AR), promoting cell proliferation. Furthermore, it has been demonstrated that nicotine, the major addictive component of tobacco smoke, can induce cell-cycle progression, angiogenesis, and metastasis of lung and pancreatic cancers. These effects occur mainly through the α7-nAChRs, with possible contribution from the β-ARs and/or epidermal growth factor receptors. This review article will discuss the molecular mechanisms by which nicotine and its oncogenic derivatives such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosonornicotine induce cell-cycle progression and promote tumor growth. A variety of signaling cascades are induced by nicotine through nAChRs, including the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway, phosphoinositide 3-kinase/AKT pathway, and janus-activated kinase/STAT signaling. In addition, studies have shown that nAChR activation induces Src kinase in a β-arrestin-1-dependent manner, leading to the inactivation of Rb protein and resulting in the expression of E2F1-regulated proliferative genes. Such nAChR-mediated signaling events enhance the proliferation of cells and render them resistant to apoptosis induced by various agents. These observations highlight the role of nAChRs in promoting the growth and metastasis of tumors and raise the possibility of targeting them for cancer therapy. Mol Cancer Res; 12(1); 14–23. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)
Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H.-G., Tsang, B. K., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312044200 · Cited by 422
RetractedPaleari, L., Catassi, A., Ciarlo, M., Cavalieri, Z., Bruzzo, C., Servent, D., Cesario, A., Chessa, L., Cilli, M., Piccardi, F., et al. (2008) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00566.x · Cited by 84
RetractedGuo, J., Kim, D., Gao, J., Kurtyka, C. A., Chen, H., Yu, C., Wu, D., Mittal, A., Beg, A. A., Chellappan, S., et al. (2012) · Oncogene · doi:10.1038/onc.2012.39 · Cited by 77
Self-citationRetractedInhibition of Nonneuronal α7-Nicotinic Receptor for Lung Cancer Treatment
Paleari, L., Negri, E., Catassi, A., Cilli, M., Servent, D., D’Angelillo, R. M., Cesario, A., Russo, P., & Fini, M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-908oc · Cited by 50
RetractedSiegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 7×
“Typically, ATM and ATR protein kinases are activated in response to double- or single-strandedDNA breaks respectively, and they stimulate downstream effectors involved in DNA damage checkpoint response including p53, Chk1, Chk2, and H2AX (62).”
InfluentialTobacco Smoke Carcinogens and Lung Cancer
Hecht, S. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1194 · Cited by 1,976
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
(2010) · PsycEXTRA Dataset · doi:10.1037/e590462011-001 · Cited by 1,803
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
Hecht, S. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1190 · Cited by 1,551
Cited by
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C.-F., Chen, W.-B., Liu, Q.-C., Li, Q.-W., Lin, Y.-Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 588
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Connections of nicotine to cancer
Grando, S. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3725 · Cited by 393
Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors
Zoli, M., Pucci, S., Vilella, A., & Gotti, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170912110450 · Cited by 259
Lochhead, P., Chan, A. T., Nishihara, R., Fuchs, C. S., Beck, A. H., Giovannucci, E., & Ogino, S. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.81 · Cited by 206
Metadata
- Authors
- Schaal, C., & Chellappan, S. P.
- Venue
- Molecular Cancer Research
- Published
- 2014-01-16
- Volume
- 12
- Issue
- 1
- Pages
- 14-23
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- OpenAlex
- W2120364751
- Cited by
- 343
- References
- 90
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-13-0541
- The paper
- Schaal, C., & Chellappan, S. P. (2014). Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-13-0541
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.